This FAQ explains the use of Cost of Good Sold Analyses (COGS) and how they inform planning for product introduction.
Cost of Goods Sold (COGS) Analyses
FAQ Debrief
Global Fund Key Numbers and Messages
Key messages and numbers to advocate for full funding of the Global Fund.
COMPASS Africa Newsletter (July 2022)
Midterm Newsletter 2022
Developed by the COMPASS MERL team, this issue offers SPARC stories and details on the MERL roadshow.
Phase 1 mRNA HIV Vaccine Trials
A breakdown of current HIV mRNA trials and a primer on the basics of mRNA technology.
Experimental mRNA-based Preventive HIV Vaccine Phase 1 Trials
The NIH announced a new study to test three mRNA-based HIV vaccine candidates. This study follows an announcement in January from IAVI about another mRNA-based HIV vaccine study. This snapshot compares the two studies.
Seven Global Civil Society Priorities for the 2021-2025 President’s Emergency Plan for AIDS Relief (PEPFAR) Strategy
As the largest funder of HIV/AIDS programming in the world, PEPFAR has the power and opportunity to move the dial. A large number of AVAC partners and other civil society organizations in Eastern and Southern Africa heard the call for comments and suggestions for the new strategy—and responded here with seven key priorities.
Tips to Approach Host Organization
A strong working relationship between a Fellow and Host Supervisor is instrumental to a successful fellowship. Fellows can be hosted by an employer or organization where they volunteer, or for an organization that aligns with project goals. This checklist supports applicants who are reaching out to prospective Host Organizations.
HIV Vaccine Research: Building on the Lessons from COVID
Building on the lessons of COVID, HIV vaccine advocates can mobilize for an HIV vaccine research and access agenda. This two-page document gives suggested messaging.
COVID Vax Tracker
The COVID Vax Tracker provides updates on COVID-19 vaccine trials worldwide. The downloadable tracker provides data on trial location, recruitment status, participant totals, inclusion criteria and more.
COVID-19 Vaccine Cheat Sheet: Access Edition
This two-pager profiles authorized vaccines with an emphasis on the “3 C’s” that have a significant impact on equitable access: cost, cold chain and manufacturing capacity.